SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine
A Pilot Study of Stereotactic Radiosurgery Combined With Nivolumab in Patients With Newly Diagnosed Melanoma Metastases in the Brain and Spine
Sponsor: Accuray Incorporated
A PHASE1 clinical study on Metastatic Malignant Neoplasm in the Brain and Metastatic Malignant Neoplasm in the Spine, this trial is completed. The trial is conducted by Accuray Incorporated and has accumulated 16 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Sep 2021 — Dec 2021 [monthly]
Recruiting PHASE1
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE1
▶ Show 11 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE1
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE1
Status: Active Not Recruiting → Recruiting
-
May 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Aug 2019 — Feb 2020 [monthly]
Recruiting PHASE1
-
Feb 2019 — Aug 2019 [monthly]
Recruiting PHASE1
-
Aug 2018 — Feb 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Accuray Incorporated
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
For direct contact, visit the study record on ClinicalTrials.gov .